Skip to content
  • info@BioLifeSolutions.com
  • 1.866.424.6543
  • Toggle search form
  • Toggle shopping cart 0

    Cart

  • Products
    • CryoStor®
      • CryoStor CS10
      • CryoStor CS5
      • CryoStor CS2
      • CryoStor CSB
    • HypoThermosol®
      • HypoThermosol®
      • HypoThermosol for Hair
    • ThawSTAR® Products
      • ThawSTAR CB
      • ThawSTAR CFT2
      • AT6
      • CFT1.5
      • CFT2 Confirmation Vials
      • Warranty and PM
      • IOP Qualification Packet
      • BioT ULT Transporter
      • BioT LN2 Transporter
      • BioT ULT Mobile Workstation
    • BloodStor®
      • BloodStor 100
      • BloodStor 55-5
      • BloodStor 27
    • Cell Thawing Media®
      • 10% Dextran 40 (IN 0.9% NaCl)
      • 10% Dextran 40 (IN 5% Dextrose)
    • All Products
  • Resources
    • Certificate of Analysis
    • Blog
    • Events
    • BioPreservation Today
    • White Papers
    • Press Releases
  • Evidence
    • Resource Links
  • Company
    • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Quality Management System
    • Distributors
    • Current Job Openings
  • Investors
    • Investors Home
    • Governance
    • Press Releases
    • Financials
    • Stock Information
    • Management Team
    • Investor Contact
  • Contact
    • General Inquiries
    • ThawSTAR Inquiries
    • Master File Request
    • SDS Request Form
    • Sample Request
    • evo Support Request
  • Ask the Scientists
  • ORDER
Close navigation
  • Primary Menu
logo

BioLife Solutions

Biopreservation Tools For Cells, Tissues, and Organs

Close search

Search

Search for:
Home/Blog/Tag: “manufacturing”/Page 2

Tag: manufacturing

How do I structure logistic processes in preparation for outsourcing of cellular therapy manufacturing?

Chen, L. N., Collins‐Johnson, N., Sapp, N., Pickett, A., West, K., Stroncek, D. F., Panch, S. R.  How do I structure logistic processes in preparation for outsourcing of cellular therapy manufacturing?  Transfusion. August 2019; 59 (8), 2506-2518.  doi:10.1111/trf.15349

Read More

Manufacturing chimeric antigen receptor T cells: issues and challenges

Roddie, C., O’Reilly, M., Dias Alves Pinto, J., Vispute, K., Lowdell, M.  Manufacturing chimeric antigen receptor T cells: issues and challenges.  Cytotherapy. March 2019; 21(3), 327-340.  doi: 10.1016/j.jcyt.2018.11.009

Read More

Biopreservation Considerations for Regenerative Medicine GMP Manufacturing

Mathew, A. J.  Biopreservation Considerations for Regenerative Medicine GMP Manufacturing; 2018.  http://ebook.liebertpub.com/biolife-solutions/biopreservation-considerations-for-regenerative-medicine-gmp-manufacturing

Read More

Biopreservation Considerations for Regenerative Medicine GMP Manufacturing

Mathew, A. J.  Biopreservation Considerations for Regenerative Medicine GMP Manufacturing; 2018.  http://ebook.liebertpub.com/biolife-solutions/biopreservation-considerations-for-regenerative-medicine-gmp-manufacturing

Read More

Development and validation of broad-spectrum magnetic particle labelling processes for cell therapy manufacturing

Harrison, R., Lugo Leija, H. A., Strohbuecker, S., Crutchley, J., Marsh, S., Denning, C., El Haj, A., Sottile, V.  Development and validation of broad-spectrum magnetic particle labelling processes for cell therapy manufacturing.   Stem Cell Res Ther, 2018 Sept 26; 9(1):248.  doi:10.1186/s13287-018-0968-0.

Read More

Off the shelf T cell therapies for hematologic malignancies

McCreedy, B. J., Senyukov, V. V., Nguyen, K. T.   Off the shelf T cell therapies for hematologic malignancies.  Best Practice & Research Clinical Haematology 2018; 31(2), 166-175.  doi: 10.1016/j.beha.2018.03.001.

Read More

Cell and Gene Therapies in Transit: Caution – Hazards Ahead: The Cell & Gene Therapy Manufacturing Pathway – Part 2

Kevin O’Donnell.  Cell and Gene Therapies in Transit: Caution – Hazards Ahead: The Cell & Gene Therapy Manufacturing Pathway – Part 2.  Cell and Gene Therapy Insights. 2016; 2(2), 271-276.  doi: 10.18609/cgti.2016.031

Read More

Technological developments for small-scale downstream processing of cell therapies

Buckler, R. L., Kunkel, E. J., Thompson, M. L. and Ehrhardt, R. O.  Technological developments for small-scale downstream processing of cell therapies.  Cytotherapy. 2016; 18(3), 301-306.  doi: 10.1016/j.jcyt.2015.12.003

Read More

Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects

Marquez-Curtis, L. A., Janowska-Wieczorek, A., McGann, L. E. and Elliott, J. A.  Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects. Cryobiology.  2015; 71(2), 181-197.  doi: 10.1016/j.cryobiol.2015.07.003

Read More

Human-Derived Raw Materials: Controlled, Consistent Collections Enable Successful Manufacturing of Cell-Based Regenerative Medicine Products

Human-Derived Raw Materials: Controlled, Consistent Collections Enable Successful Manufacturing of Cell-Based Regenerative Medicine Products

Read More

Navigation

Previous Page 1 2 3 Next Page
Search for:

Blog Archives

Signup Area

    Sign Up for Email Updates

    Biolife Logo

    • Products
    • Company
    • Evidence
    • Investors
    • Blog
    • Ask the Scientists
    • Press Releases
    • Contact
    © 2019 BioLifeSolutions Inc.  All Rights Reserved    |    Terms & Conditions    |    Privacy
    • twitter
    • linkedin
    • facebook